CNBC Indonesia
FOTO INTERNASIONAL

Paracetamol Bawa Petaka, Puluhan Anak Gambia Meregang Nyawa

Andrean Kristianto,  CNBC Indonesia
13 October 2022 18:20
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)

Mariama Kuyateh, 30, memegang foto mendiang putranya Musa yang meninggal karena gagal ginjal akut, di Banjul pada (10/10/2022) beberapa hari lalu.  Polisi Gambia pada 8 Oktober 2022, mengumumkan penyelidikan terhadap empat sirup obat batuk yang dibuat oleh perusahaan Farmasi India Maiden Pharmaceuticals. (Photo by MILAN BERCKMANS/AFP via Getty Images)

Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)

Organisasi Kesehatan Dunia (WHO) telah mengeluarkan peringatan global untuk empat sirup obat batuk dan demam asal India yang diduga memicu kematian 66 anak di Gambia. Keempat obat sirup tersebut yakni Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup dan Magrip N Cold Syrup. (AFP via Getty Images/MILAN BERCKMANS)

Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)

Sedikitnya 66 anak di Gambia, Afrika Barat, meninggal usai mengonsumsi obat batuk sirup mengandung paracetamol. Karena insiden ini, pemerintah setempat telah menarik penjualan obat-obat tersebut. (AFP via Getty Images/MILAN BERCKMANS)

Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)

Afrika adalah tujuan terbesar ketiga ekspor farmasi India yang senilai USD$ 3,83 miliar dari total ekspor senilai US$24.6 miliar pada periode 2021-2022. Antara April dan September 2022, produk farmasi India senilai US$1.87 miliar diekspor ke Afrika. (AFP via Getty Images/MILAN BERCKMANS)
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)
Mariama Kuyateh, 30, holds up a picture of her late son Musawho died from acute kidney failure, in Banjul on October 10, 2022, - Gambian police on October 8, 2022, announced an investigation into four cough syrups made by the Indian Pharma company Maiden Pharmaceuticals, after the WHO said they could be responsible for the deaths of 66 Gambian children, most under 5-years-old. Nearly half of The Gambia's population lives below the poverty line, according to the World Bank. (Photo by MILAN BERCKMANS / AFP) (Photo by MILAN BERCKMANS/AFP via Getty Images)